Price transparency made the data public. It did not make it usable.
Private equity: Underwrite with the rates, not the pitch.
Life sciences: See where the market really pays.One platform. A growing set of signals.
An answer, not a data file.
Every engagement ends in a read-out a team can take to committee. See the platform
Rate tear sheet
Provider group A · Orthopaedics · Metro area X
Illustrative · synthetic data
| Payer | Rate vs. market median (% of Medicare) | Target | Median | Percentile |
|---|---|---|---|---|
| Payer 1 | 118% | 124% | 44th | |
| Payer 2 | 96% | 122% | 21th | |
| Payer 3 | 141% | 131% | 63th | |
| Payer 4 | 104% | 119% | 29th | |
| Payer 5 | 127% | 126% | 52th |
- Below the market median with three of five payers.
- Review first: Payer 2 and Payer 4.
